Critical Outcome Technologies

December 22, 2017December 22, 2017

Phase 1 Study Showing COTI-2 Safe in Potentially Treating Advanced Ovarian and Other Cancers

News

Initial data from an early clinical trial in patients with advanced ovarian and other cancers found a potential oral therapy, COTI-2, to be safe at varying doses, supporting a more advanced ... Read more

August 23, 2017

Biotech Completes Dose Escalation Part of Phase 1 Study of COTI-2 in Gynecological Cancers

News

The dose escalation part of a Phase 1 trial evaluating COTI-2 in women with advanced gynecological cancers who did not respond to standard therapy has been completed, according to the ... Read more